enVVeno Medical Corporation Warrants
NVNOW
NVNOW was delisted on the 26th of May, 2023.
3 hedge funds and large institutions have $12K invested in enVVeno Medical Corporation Warrants in 2021 Q1 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 1 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 3 → 3 (0)
63% less capital invested
Capital invested by funds: $32K → $12K (-$20K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$20.8K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $8K | -$20.8K | -62,814 | -72% |
|
|
PAG
2
Private Advisor Group
Morristown,
New Jersey
| $3K | – | – | – |
|
|
NFSG
3
Newbridge Financial Services Group
Boca Raton,
Florida
| $1K | – | – | – |
|
NVNOW Hedge Fund Activity: Q1 2021 in Review
3 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in enVVeno Medical Corporation Warrants (NVNOW) for Q1 2021, worth a combined $12K — down 63% from $32K a quarter earlier.
Fund positioning in NVNOW was balanced in Q1 2021: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was UBS Group, cutting an estimated $20.8K.
- 3 institutional investors held enVVeno Medical Corporation Warrants (NVNOW) as of Q1 2021, unchanged from Q4 2020.
- Funds reported $12K of enVVeno Medical Corporation Warrants stock for Q1 2021, down 63% quarter-over-quarter.
- 0 funds opened new enVVeno Medical Corporation Warrants positions in Q1 2021 and 0 closed out.
- The largest enVVeno Medical Corporation Warrants seller in Q1 2021 was UBS Group, an estimated $20.8K sold.
Based on aggregated 13F filings for Q1 2021.